Business: Abbott India Limited

MOLECULE: Vi-Capsular Polysaccharide of S. typhi Ty2 conjugated to Tetanus Toxoid + Sodium chloride + water

FORM: Pre Filled Syringe

STRENGTH: Each 0.5 mL prefilled syringe contains purified Vi-Capsular Polysaccharide of S. typhi Ty2 conjugated to Tetanus Toxoid 25 μg, Sodium chloride 4.5 mg and water for Injections q.s. to 0.5 mL.

BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,Vaccine

THERAPY AREAS: Respiratory,Vaccine

Business: Abbott India Limited

MOLECULE: Inactivated Influenza Vaccine (Surface Antigen) I.P. (Quadrivalent)

FORM: Pre-Filled Syringe

STRENGTH: Influenza virus surface antigens (haemagglutinin and neuraminidase) of the following strains*:
A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238) 15 micrograms HA**
A/Thailand/8/2022 (H3N2)-like strain (A/California/122/2022, SAN-022) 15 micrograms HA**
B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26) 15 micrograms HA**
B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, wild type) 15 micrograms HA**
per 0.5 ml dose

BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,Vaccine

THERAPY AREAS: Vaccine

Read more

Business: Abbott India Limited

MOLECULE: Inactivated Influenza Vaccine (Surface Antigen) I.P.

FORM: Pre-Filled Syringe

STRENGTH: Influenza virus surface antigens inactivated (haemagglutinin and neuraminidase) of the following strains*:
A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238) 15 micrograms HA**
A/Thailand/8/2022 (H3N2)-like strain (A/California/122/2022, SAN-022) 15 micrograms HA**
B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26) 15 micrograms HA**
per 0.5 ml dose
* propagated in fertilised hens’ eggs from healthy chicken flocks
** haemagglutinin.

BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,Vaccine

THERAPY AREAS: Vaccine

Read more

Business: Abbott India Limited

MOLECULE: Purified, inactivated Japanese Encephalitis Virus protein (JE strain 821564-XY) + Aluminum Hydroxide gel + Thiomersal (Preservative) + Phosphate buffered saline

FORM: Vial

STRENGTH: Each Dose of 0.5 mL contains: Purified, inactivated Japanese Encephalitis Virus protein NLT 5.0 μg (JE strain 821564-XY), Aluminum Hydroxide gel as Al+++ IP 0.25 mg, Thiomersal (Preservative) IP 0.025 mg, Phosphate buffered saline q.s. to 0.5 ml.

BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,Vaccine

THERAPY AREAS: Vaccine

Business: Abbott India Limited

MOLECULE: Rotavirus 116E NLT 105.0 FFU + Potassium phosphate monobasic + Potassium phosphate dibasic + Sucrose + Potassium L-glutamate monohydrate + Neomycin sulphate + Kanamycin sulphate + Dulbecco’s Modi ed Eagle’s Medium + water

FORM: Vial

STRENGTH: Each 0.5 ml contains Rotavirus 116E NLT 105.0 FFU, Potassium phosphate monobasic IP 0.258 mg, Potassium phosphate dibasic IP 0.625 mg, Sucrose IP 37.31 mg, Potassium L-glutamate monohydrate 1.0 mg, Neomycin sulphate IP 15 μg, Kanamycin sulphate IP 15 μg, Dulbecco’s Modi ed Eagle’s Medium 4.4 mg and water for Injection IP q.s, pH is in the range of 7.2 to 8.0.

BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,Vaccine

THERAPY AREAS: GI & Hepato,Vaccine